Similarly, the promoting effect on the ZO-1 and occludin expressions in GP groups implies their protective capacity on the tight junction and intestinal barrier, which is the mitigative reflection on the IBD symptoms. The gene discussed is OCLN; the disease is inflammatory bowel disease.